ALPINE BIOVENTURES
Alpine BioVentures, GP, LLC is providing this website for informational purposes only. Nothing on this website is intended to constitute, or should be deemed to be, financial advisory, legal, tax, accounting or other professional advice to you or any other party; be an opinion of the appropriateness or suitability of any investment; or constitute an offer to sell or solicitation of an offer to buy any security or investment. This website and its content (collectively, “Content”) is intended for general informational purposes only and should not be acted upon without first obtaining financial advisory, legal, tax, accounting or other professional advice from your consultant or other professional with respect to your own personal investment objectives, financial circumstances and needs.
ALPINE BIOVENTURES
Social Links:
Industry:
Angel Investment Finance Venture Capital
Founded:
2015-01-01
Status:
Active
Contact:
206-441-5064
Email Addresses:
[email protected]
Technology used in webpage:
Euro Google Maps U.S. Server Location Common Name Invalid CPanel
Similar Organizations
Analytics Ventures
Analytics Ventures is a venture studio fund providing front-to-end infrastructure to ideate, form, launch, and fund new companies in AI
Redstar Ventures
Redstar Ventures is a Massachusetts-based micro venture capital that invests in startup and seed stage companies.
Zone Ventures
Zone Ventures is a partnership funded by institutional investors for the purpose of providing equity capital to young, high-growth
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-01-16 | Alpine Immune Sciences | Alpine BioVentures investment in Post-IPO Equity - Alpine Immune Sciences | 25 M USD |
| 2017-11-29 | Mavupharma | Alpine BioVentures investment in Series A - Mavupharma | 20 M USD |
| 2016-06-13 | Alpine Immune Sciences | Alpine BioVentures investment in Series A - Alpine Immune Sciences | 48 M USD |
More informations about "Alpine BioVentures"
Team - Alpine Bioventures
Prior to Alpine BioVentures, Dr. Durand was a Vice President on the life sciences investment team at Frazier Healthcare Partners, one of the first dedicated healthcare investment firms. During his time at Frazier, he was a board …See details»
Alpine BioVentures - Crunchbase Investor Profile
Alpine BioVentures, GP, LLC is providing this website for informational purposes only. Nothing on this website is intended to constitute, or should be deemed to be, financial advisory, legal, tax, accounting or other professional advice to you or …See details»
Alpine BioVentures - Investments, Portfolio & Company Exits
Alpine BioVentures 's most notable exits include Alpine Immune Sciences and Mavupharma. Which industries has this organization had the most exits in? Show . Alpine Immune Sciences …See details»
Alpine BioVentures investment portfolio - PitchBook
Alpine BioVentures's latest investment was on 29-Nov-2017 in Mavupharma, a company within the Biotechnology industry. Data Transparency. Meet our data hygiene team. Discover how …See details»
Alpine Bioventures - Top portfolio companies (Oct, 2024) - Tracxn
Alpine Bioventures has a portfolio of 3 companies. They have 3 portfolio exits. JavaScript is disabled in your browser. enable it to enjoy the full features of Tracxn.See details»
Who Owns Alpine Immune Sciences - CBM
Oct 2, 2024 Strategic Decision-Making: The ownership of Alpine Immune Sciences can impact strategic decision-making processes within the organization. Depending on whether the …See details»
Alpine BioVentures - VC Firm Profile - Gaebler.com Venture …
Alpine BioVentures brings a science-based, long term approach to every investment we make. Our unique approach ensures our portfolio companies are creating game changing …See details»
Alpine Bioventures, GP, LLC Top 13F Holdings - WhaleWisdom.com
Detailed Profile of Alpine Bioventures, GP, LLC portfolio of holdings. SEC Filings include 13F quarterly reports, 13D/G events and more.See details»
Alpine BioVentures — 2 Portfolio companies, 3 ... - Unicorn Nest
This organization was formed by Mitchell H. Gold. The standard case for the fund is to invest in rounds with 2-3 partakers. ... Alpine BioVentures is more likely to invest in rounds together …See details»
Portfolio – Alpine Bioventures
Alpine Immune Sciences. We founded and seed funded Alpine Immune Sciences in 2015 to lead the next evolution of immunotherapies. The company was created to capitalize on the founders’ unique understanding of immunology, creating …See details»
Alpine Bioventures – Startup Investor Profile – EasyVC
Alpine Bioventures is a venture capital fund based in the United States that focuses on creating companies driven by revolutionary science aimed at significantly improving patients’ lives. …See details»
Alpine BioVentures - BioCentury Company Profiles - BCIQ
Alpine BioVentures - BioCentury Company Profiles for the biopharma industrySee details»
Alpine’s Gold Standard Approach to Drug Development
Jun 23, 2020 Alpine BioVentures’ portfolio has included Gold’s current drug development company, Alpine Immune Sciences, founded in 2015; Angion Biomedica, a developer of …See details»
Alpine bags Nivalis, making Gold a public biotech CEO again
Apr 19, 2017 But with the Nivalis merger and related $17 million investment from Frazier Healthcare Partners, Alpine BioVentures and OrbiMed Advisors strengthening its finances, …See details»
Philosophy – Alpine Bioventures
The Alpine BioVentures team has relationships with leading research labs in the US and around the world to find bold scientific ideas with the potential to help people living with cancer, …See details»
Mitchell H. Gold - Co-founder Executive Chairman & CEO
Mitchell H. Gold has 2 current jobs as Co-founder Executive Chairman & CEO at Alpine Immune Sciences and Founder & Managing Partner at Alpine BioVentures. Additionally, Mitchell H. …See details»
Mitch Gold orchestrates $48M round for Alpine’s next-gen …
Jun 13, 2016 The former Dendreon CEO and current venture capitalist has pieced together a $48 million A round for Alpine Immune Sciences in Seattle, which will now look to carve out a …See details»
Alpine Immune Sciences Announces Million Series A Financing to …
Jun 13, 2016 OrbiMed Advisors. “I look forward to working with the team at Alpine to make a difference in the lives of patients with cancer, autoimmune conditions, and other serious …See details»
Ottawa biotech incubator gets $5.5M boost from federal …
Jun 25, 2024 An organization aimed at incubating Ottawa biotechnology startups says it’s poised to help several promising companies commercialize their products after secu ... Capital …See details»